The effects of percutaneous coronary intervention on mortality in elderly patients with non-ST-segment elevation myocardial infarction undergoing coronary angiography

被引:9
|
作者
Gundogmus, Pinar D. [1 ]
Olcu, Emrah B. [2 ]
Oz, Ahmet [2 ]
Tanboga, Ibrahim H. [3 ]
Orhan, Ahmet L. [2 ]
机构
[1] 29 Mayis State Hosp, Dept Cardiol, Dikmen Cd 312, TR-06460 Cankaya, Turkey
[2] Sultan Abdulhamid Han Training & Res Hosp, Dept Cardiol, Istanbul, Turkey
[3] Hisar Hosp, Dept Cardiol, Istanbul, Turkey
关键词
Acute coronary syndrome; non-ST-segment elevation myocardial infarction; percutaneous coronary intervention; conservative treatment; elderly; mortality; IN-HOSPITAL MORTALITY; CLINICAL CHARACTERISTICS; INVASIVE STRATEGY; AGE; MANAGEMENT; OUTCOMES; ROUTINE; TAIWAN; SCORE;
D O I
10.1177/0036933020919931
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Although it is recommended that elderly patients with non-ST-segment elevation myocardial infarction (NSTEMI) should undergo an assessment for invasive revascularization, these patients undergo fewer coronary interventions despite the current guidelines. The aim of the study is to evaluate the effectiveness of percutaneous coronary intervention on all-cause mortalities monthly and annually in the population. Methods: Three hundred and twenty-four patients with NSTEMI aged 65 years or older who underwent coronary angiography and treated with conservative strategy or percutaneous coronary intervention were included in the study. All demographic and clinical characteristics of the patients were recorded and one-month and one-year follow-up results were analysed. Results: Two hundred eight cases (64.19%) were treated with percutaneous coronary intervention and 116 cases (35.81%) of the participant were treated with conservative methods. The mean age of the participants was 75.41 +/- 6.65 years. The treatment strategy was an independent predictor for the mortality of one-year (HR: 1.965). Furthermore, Killip class >= 2 (HR:2.392), Left Ventricular Ejection Fraction (HR:2.637) and renal failure (HR: 3.471) were independent predictors for one-year mortality. Conclusion: The present study has revealed that percutaneous coronary intervention was effective on one-year mortality in NSTEMI patients over the age of 65. It is considered that percutaneous coronary intervention would decrease mortality in these patients but it should be addressed in larger population studies.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 50 条
  • [31] Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention
    Hamdalla, Hussam
    Moliterno, David J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (12) : 1669 - 1673
  • [32] Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Patients With Non-ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock
    Omer, Mohamed A.
    Brilakis, Emmanouil S.
    Kennedy, Kevin F.
    Alkhouli, Mohamad
    Elgendy, Islam Y.
    Chan, Paul S.
    Spertus, John A.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (10) : 1067 - 1078
  • [33] Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    Jolicoeur, E. Marc
    O'Neill, William W.
    Hellkamp, Anne
    Hamm, Christian W.
    Holmes, David R., Jr.
    Al-Khalidi, Hussein R.
    Patel, Manesh R.
    Van de Werf, Frans J.
    Pieper, Karen
    Armstrong, Paul W.
    Granger, Christopher B.
    EUROPEAN HEART JOURNAL, 2009, 30 (21) : 2575 - 2583
  • [34] Relation of lowering door-to-balloon time and mortality in ST segment elevation myocardial infarction patients undergoing percutaneous coronary intervention
    David Zahler
    Keren Lee-Rozenfeld
    Dor Ravid
    Zach Rozenbaum
    Shmuel Banai
    Gad Keren
    Yacov Shacham
    Clinical Research in Cardiology, 2019, 108 : 1053 - 1058
  • [35] Relation of lowering door-to-balloon time and mortality in ST segment elevation myocardial infarction patients undergoing percutaneous coronary intervention
    Zahler, David
    Lee-Rozenfeld, Keren
    Ravid, Dor
    Rozenbaum, Zach
    Banai, Shmuel
    Keren, Gad
    Shacham, Yacov
    CLINICAL RESEARCH IN CARDIOLOGY, 2019, 108 (09) : 1053 - 1058
  • [36] Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
    Liu, Chi
    Zhao, Qi
    Ma, Xiaoteng
    Cheng, Yujing
    Sun, Yan
    Zhang, Dai
    Liu, Xiaoli
    Zhou, Yujie
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [37] Outcomes in prediabetes vs. diabetes in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous intervention
    Kim, Yong Hoon
    Her, Ae-Young
    Jeong, Myung Ho
    Kim, Byeong-Keuk
    Hong, Sung-Jin
    Kim, Seunghwan
    Ahn, Chul-Min
    Kim, Jung-Sun
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    CORONARY ARTERY DISEASE, 2021, 32 (03) : 211 - 223
  • [38] Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
    Chi Liu
    Qi Zhao
    Xiaoteng Ma
    Yujing Cheng
    Yan Sun
    Dai Zhang
    Xiaoli Liu
    Yujie Zhou
    Cardiovascular Diabetology, 21
  • [39] Trends and In-Hospital Outcomes of Percutaneous Coronary Intervention in Non-ST-Segment Elevation Myocardial Infarction and Prior Coronary Artery Bypass Graft
    Shetty, Suchith
    Malik, Aaqib
    Aronow, Wilbert
    Liu, Kan
    Briasoulis, Alexandros
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : B19 - B20
  • [40] Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction
    Dean, Larry S.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 70 (04) : 491 - 491